| Financial Year |
March 31 2021 |
| Monetary Funds |
119,251.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
8,190.66 |
| Advances to Suppliers |
263,726.74 |
| Other Receivables |
1,686,827.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
142,597,880.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,640,114.26 |
| Total Current Assets |
315,314,212.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,600,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
16,975,642.22 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,736,347.51 |
| Other Non-Current Assets |
24,389,991.75 |
| Sub-Total of Non-Current Assets |
145,701,981.48 |
| Total Assets |
461,016,194.14 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
664,540.30 |
| Accounts Received In Advance |
75,412,636.58 |
| Employee Compensation Payable |
2,537,466.77 |
| Taxes Payable |
27,271,303.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,413,187.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
35,083.59 |
| Sub-Total of Current Liabilities |
116,604,092.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
48,760,590.71 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
48,760,590.71 |
| Total Liabilities |
165,364,683.06 |
| Paid-In Capital(Or Share Stock) |
318,600,000.00 |
| Capital Surplus |
56,306,298.82 |
| Surplus Reserve |
86,036,260.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-168,321,607.06 |
| Minority Stockholder's Interest |
3,030,559.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
292,620,951.96 |
| Owner's Equity（Stockholder's Equity） |
295,651,511.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
461,016,194.14 |
